The total prevalent population of Sciatica in the seven major markets was 27,022,660 in 2017.
In 2017, the market size of Sciatica in the 7MM was found to be USD 2,047.28 Million and is expected to grow during the study period (2017–2030).
Factors such as survival rate, improved awareness, efficient pipeline activity, increased research and development are expected to drive the Sciatica market forward in the coming years.
The key players in the Sciatica market includes Scilex Holding Company, Seikagaku Corporation, Sollis Therapeutics, SpineThera, Kolon Life Science, Teijin America, and many others.
For more detailed information on Sciatica Market, visit: https://www.delveinsight.com/report-store/sciatica-market